Xencor, Inc.
NASDAQ:XNCRBiotechnology
-$0.13 today
- Market cap
- $2.58B
- Beta
- 0.93
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$2.29
Volume 0.87M
Average 0.80M
XNCR Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Xencor, Inc.NASDAQ: XNCR
Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Financing cash flow growth accelerates
Q2 FY2026 financing cash flow of $1.03M rose 55.7% year over year, ahead of the -95.9% change in trailing-twelve-month financing cash flow. Sequentially, it rose 8.5% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.
Context
- Financing cash flow amounted to 6.6% of revenue in FY2025, down 171.9 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +55.7% holds above the trailing-twelve-month pace of -95.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 8.23M USD
- Year-over-year change
- -95.8%
- 4-year CAGR
- -33.9%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.23M | -95.8% |
| FY2024 | 2024-12-31 | 197.15M | +4.5% |
| FY2023 | 2023-12-31 | 188.72M | +3209.7% |
| FY2022 | 2022-12-31 | 5.7M | -86.8% |
| FY2021 | 2021-12-31 | 43.04M | — |
Financing Cash Flow vs competitors
How XNCR compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -95.9% is the 7th highest of 8, against a peer median of +197.0%.
- Financing cash flow amounts to 7.9% of revenue for XNCR, versus a peer median of 82.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.96B USD | — | — | 120.1% | |
| LTM Jun 2026 | $1.07B USD | +342086.6% | +392.9% | 1968.3% | |
| LTM Sep 2026 | $327.45M USD | +22878.8% | -16.3% | 292364.3% | |
| LTM Aug 2026 | $261.21M USD | +28.6% | +26.8% | 37.2% | |
| LTM Mar 2026 | $69.59M USD | +16083.5% | +247.3% | 44.3% | |
| LTM Mar 2026 | $10.47M USD | +121.3% | -60.2% | 2.7% | |
| LTM Jun 2026 | $8.3M USD | -95.9% | +13.0% | 7.9% | |
| FY2025 | €5.83M EUR | +197.0% | — | 209.2% | |
| LTM Jun 2024 | $2.15M USD | — | -37.1% | 264.1% | |
| FY2025 | A$525.12K AUD | -100.6% | — | 10.4% | |
| LTM Dec 2025 | $0 USD | — | +210.9% | 0.0% | |
| Peer median (excluding XNCR) | — | +197.0% | +26.8% | 82.2% | |
Competitors are the stored peer set for XNCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 82.63M | (55.18M) | (133.13M) | (236.54M) | (91.92M) |
| Depreciation & Amortization | 7.49M | 8.8M | 11.5M | 12.11M | 10.51M |
| Deferred Income Tax | (18.97M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 36.98M | 48.91M | 0 | 53.28M | 43.23M |
| Change in Working Capital | (102.6M) | 48.87M | 19.13M | (40.4M) | 47.45M |
| Accounts Receivables | (54.94M) | 36.86M | 19.83M | (32.67M) | 28.73M |
| Inventory | 1.4M | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.05M | (3.91M) | 3.83M | 2.85M | (3.95M) |
| Other Working Capital | (54.11M) | 15.92M | (4.53M) | (10.57M) | 22.67M |
| Other Non-Cash Items | (22.38M) | (26.91M) | 24.58M | 9.36M | (144.39M) |
| Operating Cash Flow | (16.85M) | 24.49M | (77.93M) | (202.19M) | (135.12M) |
| Capital Expenditures | (15.98M) | (43.4M) | (18.45M) | (6.1M) | (3.15M) |
| Acquisitions (Net) | (2.66M) | 0 | 501K | 0 | 0 |
| Purchases of Investments | (509.6M) | (387.93M) | (782.91M) | (595.05M) | (298.9M) |
| Sales of Investments | 485.15M | 306.61M | 693.09M | 596.66M | 427.64M |
| Other Investing Activities | (3.16M) | 90K | 0 | (3.38M) | 14.39M |
| Investing Cash Flow | (46.25M) | (119.73M) | (110.57M) | (7.87M) | 139.99M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 28.92M | 0 | 5.39M | 201.26M | 9.96M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 14.12M | 5.7M | 183.33M | (4.1M) | (1.73M) |
| Financing Cash Flow | 43.04M | 5.7M | 188.72M | 197.15M | 8.23M |
| Effect of Forex Changes | 0 | 0 | (380K) | 0 | 0 |
| Net Change in Cash | (20.06M) | (89.54M) | (152K) | (12.91M) | 13.1M |
| Free Cash Flow | (32.83M) | (18.92M) | (96.37M) | (208.29M) | (138.27M) |
Xencor, Inc.
NASDAQ:XNCR
Intrinsic Alpha fair value
Locked
Current Price
$34.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.